SLINGSHOT

70% of a stocks movement is based on public psychology factors (technical side). Only 30% is based on fundamentals.

[SLINGSHOT @SSLINGSHOTT]

$SPCX is killing our mojo.

For $CLOV holders, the interesting part is that every dollar chasing SPCX today is a dollar not chasing CLOV. Eventually it will stall after this run and money will rotate into the next story. That’s why I’d watch SPCX closely even if you hold none.

[SLINGSHOT @SSLINGSHOTT]

@GabrielPachecon He was not as condition. He was exhausted AF.

[SLINGSHOT @SSLINGSHOTT]

Adjust. Reassess. Move forward.

[SLINGSHOT @SSLINGSHOTT]

Can’t get ‘em right 100% of the time. I’ll own it.

I expected a gap to $5.25+ but
the market had other plans.

But I’d rather be wrong on timing than wrong on direction.

$CLOV is still green, still near $5, and still a lot closer to breaking out than breaking down.

[SLINGSHOT @SSLINGSHOTT]

The biggest thing I’m watching isn’t $CLOV itself. It’s whether $SPCX money starts rotating into secondary momentum names. If traders start hunting for “the next runner,” CLOV is one of the first names they’ll notice because the chart is already screaming momentum. 📈🐦😡

[SLINGSHOT @SSLINGSHOTT]

@AlbertAlan I feel money absolutely changes how you live.

The difference between someone making $50,000 and someone making $5 million isn’t just a bigger TV. 😂 It’s better quality of live overall.

So money changes how you live first. If used wisely, it can then also help you live longer.

[SLINGSHOT @SSLINGSHOTT]

If $CLOV management was willing to buy around $2.60 and authorize buybacks back in 2024, then today’s price is still nowhere near where insiders likely believe the business could be worth as profitability, star ratings, and Counterpart Health continue to improve. 🚀🌘

[SLINGSHOT @SSLINGSHOTT]

It’s gonna be a baaaaad day tomorrow for the shorts. $CLOV

[SLINGSHOT @SSLINGSHOTT]

@Tate_Brothers_ @grok Hey Haters!

Whether Tate is worth $271 B, $1 B or $50 M. The lifestyle upgrade slows down considerably after $30M. In fact, many people would find it hard to tell the difference between a lifestyle funded by $50 million and one funded by a billion dollars. #WealthSaturation

[SLINGSHOT @SSLINGSHOTT]

Oh,

🔴 10% chance of a sell-the-news reaction.

The Angry Bird is watching. 🐦😡

[SLINGSHOT @SSLINGSHOTT]

🟢 70% chance $CLOV gaps to $5.25–$5.40 and works its way toward $5.75.

Aggressive? Yes.

Unrealistic? Not with a peace deal, green futures, risk-on sentiment, and retail already in full attack mode.

🟢 20% chance we test $6–$7 if momentum and FOMO take over.

[SLINGSHOT @SSLINGSHOTT]

I don’t know about you but like @AlbertAlan I like to win 🥇

$CLOV 🚀

[SLINGSHOT @SSLINGSHOTT]

Everyone complains about Wall Street manipulation.

Then the media tells them what to buy, institutions tell them what’s hot, and they all pile into $SPCX

At some point you have to ask:

Are investors being manipulated…

Or are they voluntarily following the script?

🤔

[SLINGSHOT @SSLINGSHOTT]

Could $SPCX 4x?

Yes.

Could $CLOV 4x?

Also yes.

The difference is that for SpaceX to 4x, hundreds of billions (or trillions) of dollars in additional value must be created.

For CLOV to 4x, you’re talking about a much smaller increase in market value.

[SLINGSHOT @SSLINGSHOTT]

I’ve made a lot more money buying great companies when nobody wanted them than chasing the ones everyone already did.

Just saying. 🤷‍♂️

[SLINGSHOT @SSLINGSHOTT]

Honestly, why would you choose $SPCX over $CLOV right now??

$SPCX is already priced for perfection.

$CLOV got smacked 6% while the market chased the shiny new toy.

One is being bought because everyone loves it.

The other is being sold because everyone is distracted by it.
👇🏼

[SLINGSHOT @SSLINGSHOTT]

$SPCX closed 19% up.

The market shook every tree it could find.

Yet $CLOV finished well off the lows.

The weak hands got their scare.

Now we find out who was selling… and who was accumulating.

Monday 🚀

[SLINGSHOT @SSLINGSHOTT]

$SPCX ripped today & $CLOV is only down about 6%.

Puhlease.

If all believed CLOV was broken, we’d be trading much lower.

Instead, every dip keeps finding buyers.

You should be buying fear, not joining it.

Let the weak hands sell.

They’re provide the fuel for the next leg up

[SLINGSHOT @SSLINGSHOTT]

$CLOV isn’t down 15-20%.

It’s down about 5-6% while traders digest geopolitical uncertainty, chase the SpaceX IPO, and reshuffle capital across the market.

This is simply money moving around the board than money running away from CLOV.

There’s a difference.

We close $4.80+

[SLINGSHOT @SSLINGSHOTT]

The real question isn’t whether $CLOV is down 5-6% today.

The real question is:

6 mths from now, will today’s candle matter?

If your answer is “probably not,” then don’t make a 6-month decision based on a 3 hr chart.